NCT04377659 2025-05-28
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
Clinical Trials
7 trialsNCT04347226 2025-05-22
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Columbia University
Phase 2 Terminated
NCT05016622 2024-07-31
Booster Dose Trial
Montefiore Medical Center
Phase 2 Terminated
NCT04404361 2024-06-05
PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer
CTI BioPharma
Phase 2 Terminated
NCT04426201 2024-04-11
ILIAD-7-US-O
Revimmune
Phase 2 Terminated
NCT04447235 2022-08-09
TITAN
Instituto do Cancer do Estado de São Paulo
Phase 2 Terminated
NCT04381988 2021-10-27
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated